Stephen Colvill is an Assistant Research Director at the Duke-Margolis Institute for Health Policy, where his work focuses on leading the launch of the new Duke-Margolis ReVAMP Drug Supply Chain Consortium and other biomedical innovation topics. Stephen is also the Executive Director of RISCS, a nonprofit rating and certification organization with a mission to prevent drug shortages.
Before Duke-Margolis and RISCS, Stephen was Director, Business Analytics Team Lead, at Pfizer Injectables. He also held various other roles at Pfizer and Hospira in supply chain, manufacturing, finance, marketing, and commercial portfolio management. He serves as a board member for the End Drug Shortages Alliance and as an advisor for Angels for Change and Medicines360. He frequently speaks at national forums on pharmaceutical supply chains, drug shortages, pharmaceutical regulation, and biomedical innovation.